Get App Open
In App
Credit Cards
Open App
Loans
you are here:

Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan - IDCW

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 23.8 0.17%
    (as on 17th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 98.34% investment in domestic equities of which 27.19% is in Large Cap stocks, 25.57% is in Mid Cap stocks, 8.15% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 17th October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 10-Oct-25 10008.40 0.08% - 0.87% 184/226
1 Month 17-Sep-25 9966.50 -0.34% - 0.22% 137/225
3 Month 17-Jul-25 10012.60 0.13% - 1.48% 141/218
6 Month 17-Apr-25 10615.50 6.16% - 11.50% 188/212
YTD 01-Jan-25 9806.30 -1.94% - 4.76% 167/201
1 Year 17-Oct-24 9867.30 -1.33% -1.33% 1.73% 119/184
2 Year 17-Oct-23 15121.10 51.21% 22.93% 20.16% 39/141
3 Year 17-Oct-22 17487.40 74.87% 20.46% 21.53% 33/115
5 Year 16-Oct-20 20303.20 103.03% 15.20% 23.86% 79/91
Since Inception 10-Jul-19 31553.00 215.53% 20.09% 14.47% 33/198

SIP Returns (NAV as on 17th October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 17-Oct-24 12000 12483.07 4.03 % 7.53 %
2 Year 17-Oct-23 24000 27214.18 13.39 % 12.58 %
3 Year 17-Oct-22 36000 47327.47 31.47 % 18.58 %
5 Year 16-Oct-20 60000 89161 48.6 % 15.83 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Sep,2025)

Portfolio Turnover Ratio : 31.00%  |   Category average turnover ratio is 188.47%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 98.34% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.34%
No of Stocks : 36 (Category Avg - 44.42) | Large Cap Investments : 27.19%| Mid Cap Investments : 25.57% | Small Cap Investments : 8.15% | Other : 37.39%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 926.4 11.17% 0.21% 15.37% (Apr 2025) 10.96% (Aug 2025) 5.81 L 0.00
Apollo Hospitals Enterprises Ltd. Hospital 629.3 7.59% -0.06% 7.65% (Aug 2025) 5.89% (Oct 2024) 84.94 k 0.00
Cipla Ltd. Pharmaceuticals 566.9 6.83% -0.26% 9.11% (Jan 2025) 6.73% (Jul 2025) 3.77 L 0.00
Fortis Healthcare Ltd. Hospital 463.1 5.58% 0.43% 5.61% (Nov 2024) 4.14% (Jan 2025) 4.78 L 0.00
Abbott India Ltd. Pharmaceuticals 378.8 4.57% -0.25% 6.92% (Jun 2025) 2.57% (Jan 2025) 12.93 k 0.00
Lupin Ltd. Pharmaceuticals 375 4.52% 0.12% 5.19% (Dec 2024) 4.07% (Oct 2024) 1.96 L 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 369.1 4.45% 0.14% 8.61% (Jan 2025) 4.31% (Aug 2025) 1.02 L 0.00
Ajanta Pharma Limited Pharmaceuticals 311.2 3.75% -0.04% 4.58% (Nov 2024) 3.75% (Sep 2025) 1.29 L 0.00
Ipca Laboratories Ltd. Pharmaceuticals 294.8 3.55% -0.05% 4.19% (Dec 2024) 3.55% (Sep 2025) 2.20 L 0.00
Anthem Biosciences Ltd. Biotechnology 267.1 3.22% -0.18% 3.4% (Aug 2025) 0% (Oct 2024) 3.51 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 1.90%
Net Receivables Net Receivables -0.24%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    11.35vs12.57
    Category Avg
  • Beta

    Low volatility
    0.59vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.22vs1.01
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.23vs0.18
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    8.94vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth NA 406.67 1.76 22.88 81.42 41.31 41.84
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth NA 266.19 0.07 7.65 25.36 24.51 20.37
Franklin Asian Equity Fund - Direct - Growth NA 279.13 2.05 11.00 27.00 18.45 16.95
Nippon India Japan Equity Fund - Direct Plan - Growth NA 289.73 -1.01 11.14 18.03 17.98 20.58
DSP Banking & Financial Services Fund - Direct Plan - Growth NA 1419.62 3.56 3.20 10.57 17.37 0.00
SBI Banking & Financial Services Fund - Direct Plan - Growth NA 8693.07 3.21 2.72 10.79 16.77 21.32
ITI Banking and Financial Services Fund - Direct Plan - Growth NA 311.03 4.40 2.50 7.71 16.44 16.84
Motilal Oswal Business Cycle Fund - Direct Plan - Growth NA 1984.52 -1.63 2.98 13.42 16.32 0.00
HDFC Transportation and Logistics Fund - Direct Plan - Growth NA 1651.55 -0.64 10.81 31.36 16.04 0.00
HDFC Defence Fund - Direct Plan - Growth NA 7024.28 -1.03 0.92 23.34 15.17 0.00

More Funds from Aditya Birla Sun Life Mutual Fund

Out of 97 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 2 is/are ranked 4 * , 8 is/are ranked 3 * , 11 is/are ranked 2 * , 7 is/are ranked 1 * , and 67 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Aditya Birla Sun Life Liquid Fund - Direct Plan - Growth 1 49803.08 0.48 1.44 3.06 6.88 7.15
Aditya Birla Sun Life Large Cap Fund - Direct Plan - Growth 3 30000.77 0.96 1.86 8.71 3.56 17.51
Aditya Birla Sun Life Corporate Bond Fund - Direct Plan - Growth 2 27069.28 0.98 1.30 3.08 8.14 8.21
Aditya Birla Sun Life Money Manager Fund - Direct Plan - Growth 1 26757.31 0.53 1.48 3.48 7.79 7.74
Aditya Birla Sun Life Flexi Cap Fund - Direct Plan - Growth 3 23265.55 1.33 2.82 10.94 3.97 19.42
Aditya Birla Sun Life Arbitrage Fund - Direct Plan - Growth 5 22618.88 0.64 1.58 3.19 7.41 7.75
Aditya Birla Sun Life Savings Fund - Direct Plan - Growth 2 21367.00 0.58 1.59 3.66 7.98 7.73
Aditya Birla Sun Life ELSS Tax Saver Fund - Direct Plan - Growth 3 15174.87 0.77 2.47 12.61 4.28 16.76
Aditya Birla Sun Life Floating Rate Fund - Direct Plan - Growth 5 13401.97 0.66 1.51 3.61 8.09 7.98
Aditya Birla Sun Life Low Duration Fund - Direct Plan - Growth 1 13096.92 0.69 1.57 3.70 8.04 7.86

Forum

+ See More